Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing’s and other Small Round Cell Sarcomas

BACKGROUND: To evaluate tolerability and maintenance of dose intensity of 2 weekly treatment with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide (VDC/IE) in patients with advanced small round cell sarcomas including Ewing family tumours (EFT), desmoplastic small ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Whelan, Jeremy, Khan, Atia, Sharma, Anand, Rothermundt, Christian, Dileo, Palma, Michelagnoli, Maria, Seddon, Beatrice, Strausss, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571911/
https://www.ncbi.nlm.nih.gov/pubmed/22998944
http://dx.doi.org/10.1186/2045-3329-2-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3571911/
https://www.ncbi.nlm.nih.gov/pubmed/22998944
http://dx.doi.org/10.1186/2045-3329-2-12

Ejemplares similares